HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dana Stein Selected Research

Vaccines

1/2022rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
12/2020A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
7/2013Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dana Stein Research Topics

Disease

2Body Weight (Weight, Body)
01/2022 - 01/2021
2COVID-19
01/2021 - 12/2020
2Infections
01/2021 - 07/2004
1Vesicular Stomatitis
01/2022
1Viremia
01/2022
1Acute Lung Injury
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Botulism
12/2015
1Smallpox (Variola)
07/2013
1Cowpox
07/2013
1Tetanus
08/2009
1Alzheimer Disease (Alzheimer's Disease)
01/2009
1HIV Infections (HIV Infection)
07/2004

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
01/2022 - 07/2013
2Monoclonal AntibodiesIBA
01/2021 - 07/2013
1AntigensIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1Angiotensin-Converting Enzyme 2IBA
01/2021
1RicinIBA
01/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2021
1Subgenomic RNAIBA
01/2021
1EndopeptidasesIBA
12/2015
1Proteins (Proteins, Gene)FDA Link
07/2013
1Subunit VaccinesIBA
07/2013
1Pokeweed MitogensIBA
08/2009
1PhysostigmineIBA
01/2009
1AcetylcholinesteraseIBA
01/2009
1CarbamatesIBA
01/2009
1Rivastigmine (Exelon)FDA LinkGeneric
01/2009
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
01/2009
1Interleukin-2 (IL2)IBA
07/2004

Therapy/Procedure

2Therapeutics
07/2013 - 07/2004